These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 18931530

  • 1. MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells.
    Martin V, Jørgensen HF, Chaubert AS, Berger J, Barr H, Shaw P, Bird A, Chaubert P.
    Pathobiology; 2008; 75(5):281-7. PubMed ID: 18931530
    [Abstract] [Full Text] [Related]

  • 2. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y.
    Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420
    [Abstract] [Full Text] [Related]

  • 3. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F, Wolffe AP.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):4990-5. PubMed ID: 11309512
    [Abstract] [Full Text] [Related]

  • 4. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
    Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K.
    Pathol Int; 2004 Aug 24; 54(8):549-55. PubMed ID: 15260845
    [Abstract] [Full Text] [Related]

  • 5. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K, Enokida H, Gotanda T, Kubo H, Nishiyama K, Kawahara M, Nakagawa M.
    Biochem Biophys Res Commun; 2006 Jan 20; 339(3):790-6. PubMed ID: 16316628
    [Abstract] [Full Text] [Related]

  • 6. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M, Wu K, Fu M, Rao M, Albanese C, Russell RG, Lian H, Bregman D, White MA, Pestell RG.
    Cancer Res; 2004 Jun 15; 64(12):4122-30. PubMed ID: 15205322
    [Abstract] [Full Text] [Related]

  • 7. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G.
    Hepatology; 2002 Aug 15; 36(2):427-32. PubMed ID: 12143052
    [Abstract] [Full Text] [Related]

  • 8. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
    Tang S, Luo H, Yu J, Yang D, Shu J.
    Chin Med J (Engl); 2003 Jul 15; 116(7):1083-7. PubMed ID: 12890389
    [Abstract] [Full Text] [Related]

  • 9. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY, Chen TC, Hung SP, Chen MF, Yeh CT, Tsai SL, Chu CM, Liaw YF.
    Anticancer Res; 2002 Jul 15; 22(2B):1265-71. PubMed ID: 12168936
    [Abstract] [Full Text] [Related]

  • 10. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 11. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R, Abhilash A, Sathyan KM, Nalinakumari KR, Thomas S, Kannan S.
    Cancer Epidemiol Biomarkers Prev; 2008 Feb 25; 17(2):414-20. PubMed ID: 18268126
    [Abstract] [Full Text] [Related]

  • 12. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
    Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, Weghorst CM.
    Cancer Res; 2002 Sep 15; 62(18):5295-300. PubMed ID: 12234999
    [Abstract] [Full Text] [Related]

  • 13. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L, Eymin B, Brambilla E, Gazzeri S.
    Oncogene; 2001 Oct 04; 20(45):6587-96. PubMed ID: 11641784
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer.
    Lee M, Sup Han W, Kyoung Kim O, Hee Sung S, Sun Cho M, Lee SN, Koo H.
    Pathol Res Pract; 2006 Oct 04; 202(6):415-24. PubMed ID: 16675157
    [Abstract] [Full Text] [Related]

  • 15. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
    Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N.
    Cancer Res; 2001 Sep 01; 61(17):6335-9. PubMed ID: 11522621
    [Abstract] [Full Text] [Related]

  • 16. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
    Sharma G, Mirza S, Prasad CP, Srivastava A, Gupta SD, Ralhan R.
    Life Sci; 2007 Apr 24; 80(20):1873-81. PubMed ID: 17383681
    [Abstract] [Full Text] [Related]

  • 17. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A.
    Virchows Arch; 2002 Aug 24; 441(2):133-42. PubMed ID: 12189502
    [Abstract] [Full Text] [Related]

  • 18. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA.
    Cancer Res; 1995 Oct 15; 55(20):4531-5. PubMed ID: 7553622
    [Abstract] [Full Text] [Related]

  • 19. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 15; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G, Scheubner M, Zimmermann Y, Kalla J, Katzenberger T, Hübler K, Roth S, Hiddemann W, Ott G, Dreyling M.
    Genes Chromosomes Cancer; 2006 Feb 15; 45(2):203-10. PubMed ID: 16258956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.